These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 30260049)

  • 1. Cancer-associated fibroblasts: Secretions, interactions, and therapy.
    Farhood B; Najafi M; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2791-2800. PubMed ID: 30260049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
    Najafi M; Farhood B; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy.
    Guo T; Xu J
    Cancer Metastasis Rev; 2024 Sep; 43(3):1095-1116. PubMed ID: 38602594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal reprogramming: A target for tumor therapy.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
    Piper M; Mueller AC; Karam SD
    Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer associated fibroblasts: is the force the path to the dark side?
    Barbazán J; Matic Vignjevic D
    Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.
    Wu F; Yang J; Liu J; Wang Y; Mu J; Zeng Q; Deng S; Zhou H
    Signal Transduct Target Ther; 2021 Jun; 6(1):218. PubMed ID: 34108441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.
    Jung JG; Le A
    Adv Exp Med Biol; 2018; 1063():167-178. PubMed ID: 29946783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.
    Zhang F; Ma Y; Li D; Wei J; Chen K; Zhang E; Liu G; Chu X; Liu X; Liu W; Tian X; Yang Y
    J Hematol Oncol; 2024 Sep; 17(1):80. PubMed ID: 39223656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research Progress of Cancer-associated Fibroblasts in Lung Cancer].
    Huang C; Xu J; Li Z
    Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):267-273. PubMed ID: 32316714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
    Al-Bzour NN; Al-Bzour AN; Ababneh OE; Al-Jezawi MM; Saeed A; Saeed A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy.
    Barrett R; Puré E
    Curr Opin Immunol; 2020 Jun; 64():80-87. PubMed ID: 32402828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.